New pharmaceuticals study findings have been published by scientists at Aga Khan University

11 March 2009 Biotech Week

The researchers concluded: “These findings rationalize the medicinal use of POL-10 in cardiovascular disorders which are mediated through multiple pathways such as, antioxidant, CCB, inhibition of lipid biosynthesis and absorption.”

http://docs.google.com/Doc?id=dfvjdmwn_146g9mfw6k9